Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Dec 5, 2006
Financial News
Cylex raises $18.4 million
...joined existing investors Cahn Medical Technologies; Calvert Venture Fund; Chesapeake Emerging Opportunities; Early Stage Enterprises;
NJTC Venture Fund
...
Read More
BioCentury
|
Mar 21, 2005
Finance
Ebb & Flow
...48.9% prior to the IPO); MXL Industries (19.8%); Wheatley Partners (11.5%); Psilos Group (6.7%); and
NJTC Venture Fund
...
Read More
BioCentury
|
Dec 20, 2004
Company News
Cylex board of directors update
...Cylex Inc. , Columbia, Md. Business: Diagnostic Appointed: Robert Chefitz, a general partner in the
NJTC Venture Fund
...
Read More
BioCentury
|
Aug 23, 2004
Finance
Follow the money
...fall. Psilos Group Managers led the round. Other investors included Sanders Morris; Wheatley Partners; and
NJTC Venture Fund
...
Read More
BioCentury
|
Aug 20, 2004
Financial News
Valera raises $11.5 million
...C round led by Psilos Group Managers. Other investors included Sanders Morris; Wheatley Partners; and
NJTC Venture Fund
...
Read More
BioCentury
|
Nov 17, 2003
Company News
Linguagen board of directors update
...Linguagen Corp. , Cranbury, N.J. Business: Other Appointed: Robert Chefitz, general partner of
NJTC Venture Fund
; David Patchen...
Read More
BioCentury
|
Jun 9, 2003
Finance
Ebb & Flow
...Other investors were Investor Growth Capital; Boston Millennia Partners; Merrill Lynch Ventures; Technology Partners and
NJTC Venture Fund
...
Read More
BioCentury
|
Jun 9, 2003
Financial News
EpiGenesis raises $23 million
...Other investors included Investor Growth Capital; Boston Millennia Partners; Merrill Lynch Ventures; Technology Partners; and
NJTC Venture Fund
...
Read More
Items per page:
10
1 - 8 of 8
BioCentury
|
Dec 5, 2006
Financial News
Cylex raises $18.4 million
...joined existing investors Cahn Medical Technologies; Calvert Venture Fund; Chesapeake Emerging Opportunities; Early Stage Enterprises;
NJTC Venture Fund
...
Read More
BioCentury
|
Mar 21, 2005
Finance
Ebb & Flow
...48.9% prior to the IPO); MXL Industries (19.8%); Wheatley Partners (11.5%); Psilos Group (6.7%); and
NJTC Venture Fund
...
Read More
BioCentury
|
Dec 20, 2004
Company News
Cylex board of directors update
...Cylex Inc. , Columbia, Md. Business: Diagnostic Appointed: Robert Chefitz, a general partner in the
NJTC Venture Fund
...
Read More
BioCentury
|
Aug 23, 2004
Finance
Follow the money
...fall. Psilos Group Managers led the round. Other investors included Sanders Morris; Wheatley Partners; and
NJTC Venture Fund
...
Read More
BioCentury
|
Aug 20, 2004
Financial News
Valera raises $11.5 million
...C round led by Psilos Group Managers. Other investors included Sanders Morris; Wheatley Partners; and
NJTC Venture Fund
...
Read More
BioCentury
|
Nov 17, 2003
Company News
Linguagen board of directors update
...Linguagen Corp. , Cranbury, N.J. Business: Other Appointed: Robert Chefitz, general partner of
NJTC Venture Fund
; David Patchen...
Read More
BioCentury
|
Jun 9, 2003
Finance
Ebb & Flow
...Other investors were Investor Growth Capital; Boston Millennia Partners; Merrill Lynch Ventures; Technology Partners and
NJTC Venture Fund
...
Read More
BioCentury
|
Jun 9, 2003
Financial News
EpiGenesis raises $23 million
...Other investors included Investor Growth Capital; Boston Millennia Partners; Merrill Lynch Ventures; Technology Partners; and
NJTC Venture Fund
...
Read More
Items per page:
10
1 - 8 of 8
Previous page
Next page